Clark Wealth Partners’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-61
Closed -$29.3K 620
2026
Q1
$29.3K Sell
61
-22
-27% -$11.3K 0.02% 142
2025
Q4
$46.6K Hold
83
0.03% 112
2025
Q3
$46.6K Sell
83
-42
-34% -$18.3K 0.03% 112
2025
Q2
$39.2K Hold
125
0.03% 101
2025
Q1
$38.1K Hold
125
0.03% 108
2024
Q4
$41.5K Buy
+125
New +$42.4K 0.03% 83

Other funds holding MEDP

Clark Wealth Partners's MEDP Position: Q2 2026 in Review

Clark Wealth Partners sold out of Medpace (MEDP) in Q2 2026, closing a stake of 61 shares — an estimated $29.3K sold.

Clark Wealth Partners first reported a position in MEDP in Q4 2024 and held it in 6 quarters. The position peaked at $46.6K in Q4 2025. 661 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Clark Wealth Partners reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Clark Wealth Partners sold 61 Medpace shares in Q2 2026, an estimated $29.3K.
  • Clark Wealth Partners first reported a position in Medpace in Q4 2024 and held it in 6 quarters.
  • Clark Wealth Partners's Medpace position peaked at $46.6K in Q4 2025.
  • 661 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.